Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured ktvz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ktvz.com Daily Mail and Mail on Sunday newspapers.
Following other pharmaceutical giants, Sanofi has finally made its insulin cheaper for the public. Pharmaceutical giant Sanofi announced on Thursday that it would reduce its insulin's price by 78% effective January 1 next year.
Drugmaker Sanofi capping insulin cost at $35 for privately insured wishtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wishtv.com Daily Mail and Mail on Sunday newspapers.
Sanofi announces that it will cut the list price of Lantus (insulin glargine injection) 100 Units/mL, its most widely prescribed insulin in the U.S., by 78 percent. The company also will establish a $35 cap on out-of-pocket costs for Lantus for all patients with commercial insurance, underscoring its longstanding .
Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.